The World Health Organization has approved a version of a widely used cholera vaccine that could help address a surge in cases that has depleted the global vaccine stockpile and left poorer countries scrambling to contain epidemics.
WHO authorized the vaccine, made by EuBiologics, which also makes the formulation now used, last week. The new version, called Euvichol-S, is a simplified formula that uses fewer ingredients, is cheaper, and can be made more quickly than the old version.
The vaccine was shown to be help preventing the diarrheal disease in late stage research conducted in Nepal.
WHO’s approval means donor agencies like the vaccines alliance Gavi and UNICEF can now buy it for poorer countries. Leila Pakkala, director of UNICEF’s supply division, said in a statement that the agency will be able to boost supplies by more than 25%.
Mets rally in 7th and score the go
China's top legislator meets DPRK top leader
Ranger Suárez and Bryce Harper help the Phillies beat the Rockies 5
Bills would preferably be on the receiving end in the NFL draft after dealing Diggs to Houston
Wild moment elephant marauds through small town in Montana after breaking loose from circus
Royals C Salvador Perez out of starting lineup again with groin injury
NPR suspends editor who criticized his employer for what he calls an unquestioned liberal worldview
Harbaugh likes Chargers being in the fifth overall position going into the NFL draft
Justin Trudeau's government raises taxes on wealthiest Canadians in federal budget
Free agency left the Ravens with holes to fill as NFL draft nears, especially on the offensive line
Outfielder Tommy Pham finalizes minor league deal with slumping White Sox